Plain-English translation of NCT06561529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a medical device called the Gastric Bypass Stent System, which is swallowed and placed in the stomach to help with weight loss and potentially treat liver scarring (fibrosis). Researchers believe this non-invasive stent may help people with obesity and liver damage improve their health. The trial will involve 10 patients in Latvia and will measure how safe and effective the treatment is.
Many people with obesity develop fatty liver disease that can lead to scarring and serious liver damage over time. This trial exists to find out if the stent system can safely help these patients lose weight and reduce their liver scarring without needing surgery.
You likely qualify if…
You likely don't qualify if…
You will attend a screening visit to confirm you qualify, then return for a procedure where the stent is placed in your stomach using a camera passed down your throat (gastroscopy) — this is done under sedation. After that, you will have follow-up visits to check how well the stent is working, how much weight you've lost, and whether your liver health is improving. The entire study involves a screening phase, the procedure day, and a follow-up monitoring period.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Latvia